Serial #97901438
LIVE

Serial Number

97901438

Owner

ABBOTT DIABETES CARE INC.

Attorney

Michele H. Bowman

Filing Date

Apr 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97901438 Trademark

Serial Number: 97901438

Serial #97901438 is a trademark filed by ABBOTT DIABETES CARE INC. on April 21, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

ABBOTT DIABETES CARE INC. (142 trademarks)

100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064

Entity Type: 03

Trademark Details

Filing Date

April 21, 2023

Registration Date

Not Registered

Published for Opposition

May 13, 2025

Goods & Services

Medical apparatus and instruments for monitoring and managing diabetes, namely, blood glucose meters, blood ketone meters, biosensors, sensors for measuring analyte concentrations in interstitial fluid, sensors for monitoring analyte levels in interstitial fluid, sensors for monitoring analyte concentrations in bodily fluids, sensors for monitoring analyte levels in bodily fluids, readers for use with sensors for monitoring analyte concentrations, readers for use with sensors for monitoring analyte levels in bodily fluids, applicators for sensors worn by a human, applicators for biosensors worn by a human, insulin injectors, sold empty, insulin pens, namely, insulin injectors, sold empty, insulin dosing pens, namely, insulin injectors, sold empty, insulin pen caps, replacement caps for insulin devices, digital insulin pen caps, insulin pen caps with embedded software for collecting time and dosage data, dosing modules attachable to insulin pens, insulin syringes in the nature of pen needles, sold empty, medical infusion pumps, and insulin pumps; medical devices worn by a human for monitoring glucose, lactate and ketone levels; readers and applicators for use with medical devices worn by a human for monitoring glucose, lactate and ketone levels; medical devices for monitoring biological analytes; readers and applicators for use with medical devices for monitoring biological analytes; sensors for medical use to be worn by a human to gather physiological data; readers and applicators for use with sensors for medical use to be worn by a human to gather physiological data; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for health and medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for health and medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical wellness purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical wellness purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; sensor-based medical apparatus that tracks, gathers, measures, monitors, and determines biological analyte concentrations and analyte data for use in medical analysis; medical apparatus and instruments for use in monitoring and managing glucose, ketone, and lactate levels; medical apparatus and instruments for use in monitoring and managing biological analyte levels in fluids; medical devices, namely, patient monitors and patient sensors for monitoring, measuring, and managing biological analyte concentrations in in bodily fluids in the fields of health, wellness, and nutrition for health and medical purposes; medical apparatus and instruments for determination of analyte concentrations for health and medical purposes; electrochemical sensors that track, gather, measure, monitor, and determine biological analyte concentrations and analyte data for health and medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes and applicators and readers for use with such electrochemical sensors for health and medical purposes; glucose meters; ketone meters; medical apparatus for monitoring biological analyte levels in interstitial fluid; continuous glucose monitoring systems featuring electrochemical sensors for determination of glucose concentrations in bodily fluids for medical purposes

Insulin injectors sold filled with insulin; insulin pens, namely, insulin injectors, sold filled with insulin; insulin dosing pens, namely, insulin injectors, sold filled with insulin; insulin syringes in the nature of pen needles for injecting insulin, sold filled with insulin

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 6, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 6, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 6, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 8, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 13, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 12, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 12, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 12, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 12, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 8, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 9, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 9, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 9, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 9, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 15, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 15, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 25, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 19, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2023 NWOS
NEW APPLICATION ENTERED
Apr 25, 2023 NWAP